Neurocrine Biosciences (NBIX) Times Interest Earned (2011 - 2026)
Neurocrine Biosciences (NBIX) posted Times Interest Earned of $0.33 for Q1 2026, down 94.13% on a QoQ basis from $5.58 in Q4 2025, and down 87.09% year-over-year from $2.54 in Q1 2025.
Neurocrine Biosciences (NBIX) Times Interest Earned (2011 - 2026) Analysis & Trends
Neurocrine Biosciences' Times Interest Earned history runs 15 years deep, the most recent figure standing at $0.33 for Q1 2026.
- Quarterly Times Interest Earned fell 87.09% year-over-year to $0.33 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.34 (down 92.87% YoY) and the FY2025 annual result came in at $6.36, up 25.14% from the prior year.
- Times Interest Earned was $0.33 for Q1 2026 at Neurocrine Biosciences, down from $5.58 in the prior quarter.
- Across five years, Times Interest Earned topped out at $79.11 in Q4 2023 and bottomed at -$18.46 in Q4 2022.
- A 5-year average of $14.33 and a median of $3.08 in 2023 frame the typical range for Times Interest Earned.
- Peak annual rise in Times Interest Earned reached 985.17% in 2022, while the deepest fall reached 993.61% in 2022.
- Neurocrine Biosciences' Times Interest Earned stood at -$18.46 in 2022, then surged by 528.42% to $79.11 in 2023, then tumbled by 80.27% to $15.6 in 2024, then sank by 64.24% to $5.58 in 2025, then sank by 94.13% to $0.33 in 2026.
- Business Quant data shows NBIX's Times Interest Earned at $0.33 in Q1 2026, $5.58 in Q4 2025, and $0.39 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 13.44 |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -2.81 |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 0.18 |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -0.07 |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 0.33 |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 5.11 |
| 10 | Vireo Growth | 10.57 Bn | 10.41 Bn | 59.30 Mn | 0.03 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.33 |
| Dec 31, 2025 | 5.58 |
| Sep 30, 2025 | 0.39 |
| Jun 30, 2025 | 0.23 |
| Mar 31, 2025 | 2.54 |
| Dec 31, 2024 | 15.60 |
| Sep 30, 2024 | 5.13 |
| Jun 30, 2024 | 0.38 |
| Mar 31, 2024 | 16.28 |
| Dec 31, 2023 | 79.11 |
| Sep 30, 2023 | 41.53 |
| Jun 30, 2023 | 3.08 |
| Mar 31, 2023 | -6.84 |
| Dec 31, 2022 | -18.46 |
| Sep 30, 2022 | 73.17 |
| Jun 30, 2022 | 24.86 |
| Mar 31, 2022 | 0.78 |
| Dec 31, 2021 | -1.69 |
| Sep 30, 2021 | 6.74 |
| Jun 30, 2021 | 10.13 |